Relationship between MTNR1B (melatonin receptor 1B gene) polymorphism rs10830963 and glucose levels in overweight children and adolescents

Pediatric Diabetes

Volumn 12, Issue 4 PART 2, 2011, Pages 435-441

  Reinehr, Thomas ^a   Scherag, André ^b   Wang, Hai Jun ^b,c   Roth, Christian L ^d   Kleber, Michaela ^a   Scherag, Susann ^b   Boes, Tanja ^b   Vogel, Carla ^b   Hebebrand, Johannes ^b   Hinney, Anke ^b  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Children; Glucose; Insulin resistance; Insulin sensitivity; Lifestyle intervention; MTNR1B; Overweight

Indexed keywords

GLUCOSE; INSULIN; MELATONIN RECEPTOR; MELATONIN RECEPTOR 1B; UNCLASSIFIED DRUG;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; CHILD; CHILDHOOD DISEASE; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL;

ADOLESCENT; BLOOD GLUCOSE; CHILD; FEMALE; GERMANY; HUMANS; INSULIN RESISTANCE; LIFE STYLE; LONGITUDINAL STUDIES; MALE; OVERWEIGHT; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, MELATONIN, MT2;

EID: 79957448426     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2010.00738.x     Document Type: Article

References (35)

1. Reinehr T, Kiess W, Kapellen T, Andler W. Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics 2004: 114: 1569-1573.
2. Reinehr T, de Sousa G, Andler W. Longitudinal analyses among overweight, insulin resistance, and cardiovascular risk factors in children. Obes Res 2005: 13: 1824-1833.
3. Reinehr T, Friedel S, Mueller TD, Toschke AM, Hebebrand J, Hinney A. Evidence for an influence of TCF7L2 polymorphism rs7903146 on insulin resistance and sensitivity indices in overweight children and adolescents during a lifestyle intervention. Int J Obes (Lond) 2008: 32: 1521-1524.
4. Kelliny C, Ekelund U, Andersen LB et al. Common genetic determinants of glucose homeostasis in healthy children: the European Youth Heart Study. Diabetes 2009: 58: 2939-2945.
5. Lyssenko V, Nagorny CL, Erdos MR et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 2009: 41: 82-88.
6. Prokopenko I, Langenberg C, Florez JC et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet 2009: 41: 77-81.
7. Sparso T, Bonnefond A, Andersson E et al. G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19, 605 Europeans. Diabetes 2009: 58: 1450-1456.
8. Staiger H, Machicao F, Schafer SA et al. Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function. PLoS One 2008: 3: e3962.
9. Bouatia-Naji N, Bonnefond A, CavalcantiProenca C et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2009: 41: 89-94.
10. Von GC, Stehle JH, Weaver DR. Mammalian melatonin receptors: molecular biology and signal transduction. Cell Tissue Res 2002: 309: 151-162.
11. Radziuk J, Pye S. Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour? Diabetologia 2006: 49: 1619-1628.
12. Peschke E, Frese T, Chankiewitz E et al. Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J Pineal Res 2006: 40: 135-143.
13. Reiling E, van 't Riet E, Groenewoud MJ et al. Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk. Diabetologia 2009: 52: 1866-1870.
14. Ronn T, Wen J, Yang Z et al. A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals. Diabetologia 2009: 52: 830-833.
15. Peschke E. Melatonin, endocrine pancreas and diabetes. J Pineal Res 2008: 44: 26-40.
16. Ramracheya RD, Muller DS, Squires PE et al. Function and expression of melatonin receptors on human pancreatic islets. J Pineal Res 2008: 44: 273-279.
17. Peschke E, Stumpf I, Bazwinsky I, Litvak L, Dralle H, Muhlbauer E. Melatonin and type 2 diabetes - a possible link? J Pineal Res 2007: 42: 350-358.
18. Stancakova A, Kuulasmaa T, Paananen J et al. Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5, 327 nondiabetic Finnish men. Diabetes 2009: 58: 2129-2136.
19. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000: 320: 1240-1243.
20. Kromeyer-Hauschild K, Wabitsch M, Geller F et al. Percentiles of body mass index in children and adolescents evaluated from different regional German studies. Monatsschr Kinderheilkd 2001: 149: 807-818.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985: 28: 412-419.
22. Katz A, Nambi SS, Mather K et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000: 85: 2402-2410.
23. Ye S, Dhillon S, Ke X, Collins AR, Day IN. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001: 29: E88.
24. Reinehr T, de Sousa G, Toschke AM, Andler W. Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention. Am J Clin Nutr 2006: 84: 490-496.
25. Reinehr T, Kersting M, Wollenhaupt A et al. Evaluation of the training program "OBELDICKS" for obese children and adolescents. Klin Padiatr 2005: 217: 1-8.
26. Reinehr T, Temmesfeld M, Kersting M, de Sousa G, Toschke AM. Four-year follow-up of children and adolescents participating in an obesity intervention program. Int J Obes (Lond) 2007: 31: 1074-1077.
27. Reinehr T, Kleber M, Lass N, Toschke AM. Body mass index patterns over 5 y in obese children motivated to participate in a 1-y lifestyle intervention: age as a predictor of long-term success. Am J Clin Nutr 2010: 91: 1165-1171.
28. Reinehr T, Brylak K, Alexy U, Kersting M, Andler W. Predictors to success in outpatient training in obese children and adolescents. Int J Obes Relat Metab Disord 2003: 27: 1087-1092.
29. Kleber M, Schaefer A, Winkel K et al. Lifestyle intervention "Obeldicks Mini" for obese children aged 4 to 7 years. Klin Padiatr 2009: 221: 290-294.
30. Franks PW, Jablonski KA, Delahanty LM et al. Assessing gene-treatment interactions at the FTO and INSIG2 loci on obesity-related traits in the Diabetes Prevention Program. Diabetologia 2008: 51: 2214-2223.
31. Jonsson A, Renstrom F, Lyssenko V et al. Assessing the effect of interaction between an FTO variant (rs9939609) and physical activity on obesity in 15, 925 Swedish and 2, 511 Finnish adults. Diabetologia 2009: 52: 1334-1338.
32. Wardle J, Llewellyn C, Sanderson S, Plomin R. The FTO gene and measured food intake in children. Int J Obes (Lond) 2009: 33: 42-45.
33. Sabatti C, Service SK, Hartikainen AL et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 2009: 41: 35-46.
34. Langenberg C, Pascoe L, Mari A et al. Common genetic variation in the melatonin receptor 1B gene (MTNR1B) is associated with decreased early-phase insulin response. Diabetologia 2009: 52: 1537-1542.
35. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med 2002: 19: 527-534.